Lancet Diabetes Endocrinol 2021;9:825-36.ArticlePubMed 129
Always consult your doctor before starting if you have underlying conditions or take prescription medications, especially those for blood sugar regulation
GIP activation appears to complement GLP-1 effects synergistically rather than additively, which explains why Tirzepatide (dual agonist) produces significantly more weight loss than Semaglutide (single agonist) despite both activating GLP-1
To the best of a persons knowledge, they must answer any healthcare professionals questions to help reduce the risk of severe and possibly fatal side effects
Interestingly, our MS interactomic analysis also identifies TAMM41, an essential enzyme for the biosynthesis of cardiolipin 71 , as an active GLP-1R interactor
Additionally, GLP-1 agonists slow gastric emptying, which contributes to prolonged fullness after meals